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The ability of humoral products of the immune response to regulate the response 
is well known  (1).  Serum from immune individuals, passively administered to normal 
recipients, can  suppress both  the  rejection of grafted  tissues  (2)  and  the  antibody 
response  to  homologous antigen  (3).  The  possibility that  the  two  phenomena  were 
distinct emerged with the realization that two different populations of lymphoid cells 
were  involved.  Thymus-independent,  bone  marrow-derived  lymphocytes  (B  cells) 
are the line of cells that can ultimately mature to antibody production. The lympho- 
cytes responsible for cellular immunity and that also may subserve a  helper function 
in humoral antibody production (T cells) require the influence of the thymus for their 
maturation (4,  5).  The production of antihapten antibody in response to  immuniza- 
tion with hapten-carrier conjugates involves cooperation of T  cells and B cells  (6,  7), 
the former reacting with carrier specificities and the latter with the haptenic determi- 
nant, and may also involve macrophages (8-10). Any or all of these may be susceptible 
to suppression by humoral factors. 
Several  workers  have  found  evidence  that  hyperimmune  serum  can  inhibit  the 
processing by  macrophages  of  heterologous erythrocytes to  an  immunogenic form 
(11-13).  Suppression of  B  cell  maturation  and  proliferation by antibody probably 
represents direct competition for antigen between B  cell receptors and antibody (14), 
and it is reported that this may occur without concomitant suppression of T cells (15). 
However,  suppression  of  T  cell  development  and/'or  function  by  humoral  factors 
occurs  in  both  natural  and  induced  enhancement  of  antigenically foreign  tissues 
(2,  16-18). 
In addition to immunosuppression induced by humoral factors, it has been estab- 
lished that relatively small doses of passively administered immune serum may cause 
augmentation of antibody production.This effect has been variously ascribed to IgM 
antibody presumably directed against the haptenic determinant (19),  or to antibody 
directed  against  new  antigenic  determinants  introduced  into  the  carrier  molecule 
during the process of haptenation (20-22). 
The series of experiments reported in this paper were designed to elucidate the 
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regulatory role of antibody. We have employed antisera raised against a  family 
of  related  haptens  coupled  to  non-cross-reacting  protein  carriers  both  before 
and after absorption with insoluble immun.oadsorbents. We have measured the 
effect of passive administration of these sara on the level of the antihapten  re- 
sponse to a  standard  challenge with hapten-carrier conjugate. 
Anticarrier sara cause  a  modest degree of immunosuppression when adminis- 
tered  in high doses.  Antihapten  sara  are  strongly  immunosuppressive  in high 
doses but augment the response in low doses. Suppression and augmentation  are 
due to distinct populations of antibodies, suppression being a  function of anti- 
hapten  antibodies and augmentation  a  function of  antibodies directed  against 
specificities introduced into any of the protein carriers as a  result of conjugation 
with any of the family of haptens. 
Materials  and Methods 
Mice.--Two  strains were used.  Donors of the suppressing anti-NIP-CG  1 antiserum were 
outbred white mice. For other purposes we used  (CBA  X  C57)F1 bred in this laboratory. 
The origin of the CBA parent was the National Institute for Medical Research, London, and 
the origin of the C57BL/6 the Jackson Laboratory, Bar Harbor, Maine. 
Antigens  and  Haptens.--The  haptens  NIP  (3-nitro-4-hydroxy-5-iodophenylacetic ~cid), 
NP (3-nitro-4-hydroxyphenylacetic acid), or HOP (4-hydroxyphenylacetic acid) were coupled 
to chicken globulin (CG),  bovine serum albumin (BSA),  or ovalbumln  (OA)  as previously 
described (23). 
Preparation  of Immunosuppressive  Antlsera.--An  emulsion of complete Freund's adjuvant 
(CFA) with an equal volume of NIP12-CG (l mg/ml in saline) was prepared. Each of 30 out- 
bred white mice received four injections of 50 #I of this emulsion, one in each axillary and 
inguinal region. 3 wk later this treatment was repeated and after a further 6 wk each mouse 
was injected intraperitoneally (i.p.)  with 300 #g of alum-precipitated NIP12-CG in 0.3 ml of 
saline. The mice were bled from the retro-orbital sinus 10 days after the last injection, the 
serum was separated, and after a small sample had been saved from each mouse the bulk was 
pooled for storage in small aliquots at --20°C. 
Antisera to NIP4-OA and to CG were prepared in a  similar fashion except that the mice 
were (CBA X  C57)F1 and the first injection in CFA was omit/ed. All mice used for prepara- 
tion of these sara were females. 
Immunoadsorbenls.--Agarose  (Sepharose 4B; Pharmacia, Uppsala, Sweden) was activated 
according to Porath et al.  (24). The beads were washed twice with 10 vol of water and packed 
Sepharose (1 vol) was suspended in an equal volume of water. The mixture was placed on a 
magnetic stirrer at room temperature and 6 vol of 1% CNBr in water was added. The mixture 
was incubated for 1 min at pH 4-5 and the electrode of a pH meter was put into the mixture. 
Then enough I  N  NaOH was added to keep the pH at  10.5  -4- 0.5.  When 0.4 vol of NaOH 
had been added the mixture was poured into 60 vol of 0.1  M  NaHCO:~  and the beads were 
washed in a Btichner funnel with 120 vol of 0.l M  NaHCO3. 
Activated Sepharose was suspended into 2 vol of 0.1 M  NaHCO~ and 600 mg of protein 
was added. The mixture was incubated overnight at 4°C. The beads were washed in a sintered 
glass funnel with 10 vol of borate buffer, 10 vol of 8 M  urea,  ]0 vol of citrate buffer pH 2.6, 
1 Abbreviations  used in this" paper:  ABC,  antigen-binding capacity; ABC30,  reciprocal of 
serum dilution at which 30% of 10  -s M  free hapten is bound; BSA, bovine sermn albumin; 
CFA,  complete  l:reund's  adjuvant;  CG,  chicken  globulin;  EDA,  ethylenediamine; HOP, 
4-hydroxyphenylacetic acid; NIP, 3-nitro-4-hydroxy-5-iodophenylacetic acid; NP, 3-nitro-4- 
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10 vol of carbonate buffer pH 10, 10 vol of saline, and 10 vol of 0.05 M ethanolamine in borate 
buffer. The first five steps were repeated. 
For the preparation of hapten-immunoadsorbents the procedure was the above except that 
instead of protein,  75  mg of NIP-ethylenediamine (NIP-EDA)  was added.  NIP-EDA was 
prepared according to Hoffman et al. (25). 
The two haptens used in the immunoadsorbents, HOP and NIP, are slightly cross-reactive 
but  both  reciprocal  Krel  values  (HOP  vs.  anti-NIP  and  NIP  vs.  anti-HOP)  are  too 
]ow (<0.0001)  to be measured accurately (O.  M/ikel~, unpublished experiments). 
Standard Experimental Design.--All mice used  were (CBA X  C57)F1 hybrids between 12 
and 30 wk of age. Within any single experiment all mice were of the same sex and differed in 
age by not more than 5 wk. 
Groups of five mice were injected i.p. with 0.2 ml of appropriately diluted antiserum in saline 
so that  each mouse received from 0.01  to 100/zl  of original serum. Between 16 h  and 24 h 
later these mice, plus a group of controls that had been injected with saline, received 50 #g of 
alum-precipitated NIP12-CG i.p. The mice were bled from the retro-orbital sinus under light 
ether anesthesia 11  and  19 and in some cases 42 days after antigen. The sera were titrated 
individually  to  determine their  antigen-binding capacity  (ABC)  for  125I-labeled  NIP-cap 
(26).  Hapten was present in the mixtures with serum dilutions at  a  final concentration of 
10  -8 M. The data used are observed values for ABC when 30c7~ of the hapten was bound and 
are presented as the geometric mean value of each group 4- the standard error. The significance 
of difference between groups was determined by Student's t test. 
RESULTS 
Suppression of the Primary Response to NIP12-CG by Homologous  Antiserum.- 
Various  doses  of  hyperimmune  anti-NIP12-CG  ranging  from  0.1  to  10  #l 
were given to groups of five (CBA X  C57)F1 o  ~ mice, which were then chal- 
lenged  with  50  #g  of  alum-precipitated  homologous  antigen.  Production  of 
NIP-binding antibody was followed for 6 wk. Data  are  presented in  Figs.  1 
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FIO.  1.  Suppression of the anti-NIP response to 50 #g of alum-precipitated NIPI~-CG by 
various doses of hyperimmune homologous antiserum given 16 h before challenge. Logl 0 ABC ~  0 
of the injected antiserum was 4.08. Data are from groups of five (CBA X  C57)F1 o  ~ mice bled 
20 days after antigen injection. *P <  0.05; **P <  0.01, ***P <  0.001. 2.5 
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and 2. A dose of 0.3 ~l of antiserum or greater caused  a  significant degree of 
immunosuppression. The immunosuppressive effect was greater early in the re- 
sponse than late. Recipients of 10 ~1 of antiserum (the highest dose tested) did 
not produce detectable levels of antibody during the first 20 days, but by 42 
days they had caught up to within about 50% of control levels. 
The  ABC30 of  the  hyperimmune serum  used  for immunosuppression  was 
1.2  X  10  .4 M. The dose of antigen used contained approximately 3.3  X  10  .9 
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Fro. 2.  Production  of NIP-binding antibody  after injection  of various doses of anti-NIP- 
CG antiserum and challenge with 50 #g of alum-precipitated  NIP12-CG. For details see Fig.  1. 
mol of NIP and thus a dose of 0.3/~l of antiserum contained only sufficient anti- 
body to bind about 1% of the administered hapten. 
From  this  experiment,  it  could  not  be  determined  whether  immunosup- 
pression was a function of antihapten antibody, presumably operating at the B 
cell level, or of anticarrier, presumably operating on the helper T cells. 
Influence  of Anticarrier  and  Antihapten  Sera  on  the  Primary  Response  to 
NIP~2-CG.--Various  doses  of  hyperimmune  serum  prepared  against  CG  or 
NIP4-OA were administered to groups of five (CBA)~  C57)F1  Q  mice, which 
were then challenged with 50/~g of alum-precipitated NIP12-CG.  Production of 
NIP-binding  antibody was  followed. Data  from the  mice treated  with  anti- 
carrier and with antihapten are presented in Figs. 3 and 4 and Figs. 5 and 6, re- 
spectively. High doses of anti-CG (10 and 100 ~l) caused a modest but staffs- 2.5 
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FIG. 3.  Influence of anticarrier serum on the primary anti-NIP response to 50 #g of alum- 
precipitated NIPI~-CG. Groups of five (CBA X  C57) F1  9  mice were given various doses of 
hyperimmune anti-CG 16 h  before antigen and bled 19 days later. The probability that the 
observed differences between experimental and control groups is due to chance is indicated by 
asterisks as in Fig. 1. 
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FI6.  4.  Production  of NIP-binding antibody after injection of various doses of anti-CG 
serum and challenge with 50 #g of alum-precipitated NIP12-CG. For details see Fig. 3. 3.0 
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FIG. 5. Influence of antihapten serum on the primary anti-NIP response to 50 #g of alum- 
precipitated NIP12-CG.  Groups of five (CBA M C57)F1  ~  mice were given various doses of 
hyperimmune  anti-NIP4-OA  16 h  before antigen and  bled  19  days  later.  The  probability 
that the observed differences between experimental and control groups is due to chance is indi- 
cated by asterisks as in Fig.  1. 
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Fla, 6. Production of NIP-binding antibody after injection of various doses of anti-NIP4- 
OA serum and challenge with 50 #g of alum-preclpitated  NIP12-CG.  For details see Fig.  5, G.  HAUGHTON  AND  O.  M*KELA  109 
tically significant degree of immunosuppression. By 19 days after antigen these 
doses of antiserum caused about 35 and 60 % reduction, respectively, in anti- 
NIP antibody below control levels. Lower doses of anti-CG had no discernible 
effect. 
By contrast,  a  high  dose  (100 /zl) of anti-NIP4-OA  serum  suppressed  the 
anti-NIP response at 19 days by about 99% while low doses (0.1 or 1.0 #1) in- 
creased the response about twofold. Both suppression  and  elevation of anti- 
body production were most pronounced early in the response. At ll and 19 days 
after antigen, both low doses caused significant elevation of the response and 100 
#1 caused almost total suppression. By 42 days after antigen, the group treated 
with  100 #1 of serum were no longer fully suppressed and the groups treated 
with lower doses had antibody titers similar to those in control mice. 
Influence  of Absorbed Antisera on the Primary Response  to NIP12-CG.--The 
question of whether both suppression and elevation of the response are due to 
anti-NIP antibodies present in the serum raised against NIP4-OA, or whether, 
as suggested by Rubin (21), elevation was due to antibodies against new anti- 
genic determinants introduced into the protein molecule in the course of hap- 
tenation was  approached by absorbing the anti-NIP4-OA serum with hapten 
coupled to insoluble Sepharose. 
Anti-NIP4-OA  serum  was  diluted  l: 10  and  absorbed  with  [  vol of NIP- 
Sepharose. The mixture was stirred at 4°C for 8 h, the beads were removed by 
centrifugation, and the supernatant was used. A control sample of serum, which 
was not absorbed, was kept in diluted form at 4°C for the period of the absorp- 
tion. Before absorption the ABC30 of the serum was 870 (8.7 ;<  10  -8 M); after 
absorption it was reduced to less than 0.8 (8 ×  10  -~ M). 
Various doses of the absorbed or unabsorbed serum were given to groups of 
five (CBA  X  C57)Fj  c~ mice, which were then challenged with 50 ~g of alum- 
precipitated NIP12-CG.  Anti-NIP  titers in  the bleedings taken  19 days after 
antigen are shown in Fig. 7. Removal of more than 99.9 % of the NIP-binding 
antibodies from the serum by absorption with NIP-Sepharose did not diminish 
the "helper" effect of the anti-NIP4-OA serum. In fact, at all doses tested, a 
greater elevation of the response occurred in mice given absorbed serum than in 
those given unabsorbed  serum. The data are  consistent with  the hypothesis 
that  immunosuppressive activity is  a  function of hapten-specific antibodies, 
but that the observed helper effect is due to antibodies directed against a new 
antigenic determinant introduced into the protein carrier as a result of coupling 
the hapten to the lysine residues  of  the  protein. This  new  antigenic  deter- 
minant would not be created by coupling NIP to carbohydrate and thus anti- 
bodies  directed  against  it  would  not  be  removed  by  absorption  with  NIP- 
Sepharose. 
We argued that if the hypothesis were correct, a  similar new antigenic de- 
terminant might be created by coupling a different, but chemically related, hap- 
ten to a protein carrier. Furthermore, if the new antigenic determinant resulted 
from the union between hapten and lysine, the nature of the protein carrier 110  IMMUNOSUPPRESSION  OR  AUGMENTATION  BY  ANTIBODY 
might not  be important;  a  similar new  antigenic determinant might occur in 
any protein coupled through a lysine residue to any hapten of this family. 
As  a  test  of  this prediction,  two  equal  samples of anti-NIP4-OA were  ab- 
sorbed:  the  one  with  NIP-EDA-Sepharose  and  the  other  with  HOP-BSA- 
Sepharose. Equivalent volumes of the two absorbed sera were given to groups of 
five (CBA X  C57)F1  9  mice followed by challenge with 50 >g of Mum-precipi- 
tated  NIPL,-CG. The  ABCa0 of the resulting antisera taken  13  days later are 
shown  in  Fig. 8.  Absorption with NIP-Sepharose had  removed  all detectable 
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Fro. 7. Effect of removing NIP-binding antibodies from hyperimmune anti-NIP4-OA on its 
ability to augment  the anti-NIP response to primary challenge with NIP12-CG. A sample of 
anti-NIP4-OA was  absorbed with NIP-EDA-Sepharose, thereby reducing  its  NIP-binding 
capacity by more than 99.9%. Various doses of absorbed or unabsorbed serum were given to 
groups of five (CBA X C57)F1 c{ mice 16 h before challenge with 50 #g of alum-precipitated 
NIP12-CG.  The mice were bled 19  days after antigen.  The probability that the observed 
differences between control and experimental groups is due to chance is indicated by asterisks 
as in Fig. 1. 
suppressing  antibody; not  even  100  /~l caused  any  suppression.  We conclude 
from this that most of the suppressing antibody in this serum was specific for 
NIP. This absorption had not reduced the helper effect. Thus the helper factor 
in the anti-NIP-OA serum probably was not anti-NiP. Absorption with HOP- 
BSA-Sepharose had removed the helper antibody, and somewhat surprisingly, 
also the component responsible for potent immunosuppression. We did not ex- 
pect  this  because  there  is very  little cross-reaction between  NIP  and  HOP 
tested by the conventional methods. 
To  test  whether  helper  antibody was  species specific,  an  antiserum  raised G.  HAUGHTON  AND  O.  MAKELA  111 
in  rabbits  against  NP-CG  was  examined.  Antihapten  antibodies  would  be 
poorly cross-reactive with  NIP  and  would  not  be immunosuppressive.  How- 
ever, the serum likely contained anticarrier antibodies, which could be immuno- 
suppressive,  as well  as the postulated helper antibodies directed against new 
antigenic determinants. It was,  therefore, absorbed with CG-Sepharose before 
testing. Data from  the test of this absorbed serum are given in  Fig. 9.  At all 
2.0 
ht 
U) 
+l  I. 5 
g 
< 
Z 
LU 
_o  1.0 
(.9 
O 
.2 
TAbs.  NIP-Seph.j,,~l'~'~- 
I  //  I  I  I  I  NIL  0.1  I  I0  I00 
DOSE OF  SERUM (~ul) 
FIG. 8.  Effect  of removing  antibodies against NIP or against postulated new  antigeni 
determinants from anti-NIP4-OA on its ability to augment the primary anti-NIP response to 
NIP12-CG. Samples of anti-NIP4-OA serum were absorbed with NIP-EDA-Sepharose or with 
HOP-BSA-Sepharose.  Various  doses  of the  absorbed sera were  given to  groups  of  five 
(CBA X  C57)F1  9  mice 16 h before challenge with 50 #g of alum-precipitated NIP12-CG. 
The mice were bled 13 days after antigen.  The probability that the observed differences be- 
tween pairs of experimental groups injected with equal doses of the two absorbed sera is due 
to chance is indicated by asterisks as in Fig. 1. 
doses tested, the experimental mice gave an elevated response. At the two lower 
doses, this elevation was highly significant (P  <  0.01). 
Sex.--During the course of this  and  related work,  we noted  that  the anti- 
body response observed in  groups of control mice varied from one experiment 
to another.  Upon examination it became clear that this variation was sex re- 
lated,  females  producing  higher  antibody  titers  in  response  to  a  standard 
primary dose of 50 #g of alum-precipitated NIP12-CG. Data from all (CBA X 
C57)F1 control mice are presented in Fig. 10. It is clear that female mice give a 
higher and more prolonged response to the standard primary challenge than do 
males. 112  IMMUNOSUPPRESSION  OR  AUGMENTATION  BY  ANTIBODY 
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FIc. 9. Augmentation  of the primary anti-NIP response of mice to NIP12-CG by various 
doses of rabbit anti-NP-CG absorbed with CG-Sepharose.  Groups of five (CBA X  C57)F1 
mice were given various doses of the absorbed serum  16 h  before 50/~g of alum-precipitated 
NIP12-CG. They were bled 13 days later. The probability that the observed differences between 
control and experimental groups is due to chance is indicated by asterisks in Fig. 1. 
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171o. 10. The influence of sex on the primary anti-NIP response of normal (CBA  X  C57)F1 
mice to 50/~g of alum-precipitated NIP12-CG. Each point represents data from 13-25 females 
(upper curve) or males. The probability that the difference between the sexes is due to chance 
is indicated by asterisks as in Fig.  1. G.  HAUGHTON  AND  O.  MAKELA  113 
DISCUSSION 
Suppression of the immune response by passive antibody operates through 
competition  for  antigen  between  antigen  receptors  on  lymphocyte  surfaces 
and the administered antibody (14). In the case of thymus-dependent antigens, 
when  both  T  cells  and  B  cells  must  interact  with antigen  before antibody 
production occurs, it is not clear whether competition occurs only at the B cell 
level, or whether passive antibody may also interfere with the T  cell response. 
In  an  attempt  to  attack  this  question  directly, we have  administered  anti- 
hapten  or  anticarrier  antibody  and  observed  the  effect on  the  response  to 
challenge with hapten-carrier conjugate. As expected, relatively large doses of 
hyperimmune antihapten  serum  caused  almost  complete suppression  of  the 
response,  probably by direct competition with  B  cell receptors. Suppression 
of the response by homologous antiserum (Fig. 2) or antihapten serum (Fig. 4) 
was not permanent; some antibody production was seen between 3 and 6 wk 
after immunization, indicating relatively long persistence of the administered 
antigen. 
Administration  of high  doses  of anticarrier serum  caused  a  moderate but 
highly significant suppression  of the  antihapten  response.  Clearly this  effect 
was not due to direct competition with B cell receptors, but to reaction of anti- 
body with  that portion  of the  antigen  that  is  recognized by helper T  cells. 
One may not conclude that antibody competes directly with T  cell receptors, 
since there is no evidence that anticarrier serum reacts with the same determi- 
nants on the molecule as do the T cell receptors. Nonetheless, some mechanism 
other than direct competition with B  cells must be postulated to explain the 
observed effect. 
We have earlier described an inhibitory effect of passive antiserum on antigen 
handling by macrophages (13), and it is well established that humoral products 
of the immune response can inhibit T  cell functions such as graft rejection (2, 
16,  17)  and in vitro cytotoxicity (18). We conclude that helper function of T 
cells can similarly be inhibited. 
While high doses of antihapten serum caused almost total suppression of the 
immune response, very much lower doses elevated the response above control 
levels. Other examples of a positive influence of passive antiserum have been 
reported (19-22). The effect has been ascribed either to a macromolecular com- 
ponent of the  serum,  presumed  to  be IgM,  or to  antibody directed against 
nonhapten determinants newly introduced into the carrier molecule as a con- 
sequence of the coupling with hapten. The phenomenon that we have observed 
is more akin to the latter than to the former. IgM anti-NIP seems not to be in- 
volved for  the  following reasons.  The  serum  in  question  was  a  product  of 
hyperimmunization, unlikely to contain very much IgM antibody. In accord- 
ance with  this  prediction,  the  anti-NIP  activity of the  serum was  found in 
bacteriophage  neutralization  tests  (27)  to  be  highly  resistant  to  mercapto- 
ethanol (O.  Mitkelii, unpublished data). The helper activity was not removed 114  IMMUNOSUPPRESSION  OR  AUGMENTATION BY  ANTIBODY 
by absorption with NIP-Sepharose,  which reduced the ABC for NIP-cap by 
more than 99.9 %. However, the activity could be removed by absorption with 
HOP-BSA-Sepharose, an antigen whose haptenic group cross-reacts very poorly 
with NIP. 
Antiserum raised in rabbits against NP-CG and absorbed with CG-Sepharose 
also  demonstrated  helper  activity.  The  determinant  NP  also  cross-reacts 
poorly with  NIP  (28) and  the  antihapten  antibodies  did  not  suppress  the 
anti-NIP response to NIP-CG. 
Thus, the characteristics of helper antibody as delineated in this study are 
as follows. It is not directed against the haptenic group or against the native 
carrier,  but against a  new antigenic determinant introduced into the carrier 
as  a  result  of  haptenation.  The  determinant  is  neither  hapten-specific nor 
carrier-specific but seems to be introduced into any of the three proteins tested 
(CG, OA, BSA) by the process of haptenation through lysine with any hapten 
of the NIP family. This implies that the determinant in question is adjacent 
to the introduced hapten and suggests a possible mode of action of the helper 
antibody. After antigen degradation,  only those fragments carrying hapten 
would  express  the  new  antigenic  determinant  and  thus,  hapten  carrying 
fragments would be specifically susceptible to aggregation by helper antibody 
providing a high local concentration of hapten for stimulation of B cells. The 
question of whether helper antibody can substitute for helper T  cells  as sug- 
gested in the models studied by Rubin (21, 22)  or whether the effect is only 
supplementary cannot be answered from our data. 
SUMMARY 
We  have  measured  the  production  by  (C57  X  CBA)FI  mice  of  hapten- 
binding antibody in response to a standard dose of 50 #g of alum-precipitated 
NIPu-CG  and  the  influence on  this  response  of the prior  administration  of 
hyperimmune antisera  raised  against the  homologous  conjugate, the  carrier 
globulin  alone,  the  hapten  conjugated  to  a  non-cross-reactive  carrier 
(NIP4-OA), or a related hapten (NP) coupled to CG. 
The homologous antiserum was strongly immunosuppressive; a dose capable 
of binding about 1% of the administered hapten caused significant suppression. 
High  doses  of  anticarrier  serum  caused  significant but  modest  suppression 
(about 50 %) ; low doses had no effect. High doses of the serum prepared against 
NIP4-OA suppressed the 19 day response by more than 97%, while 100-1,000 
times lower doses caused the response to be elevated to about double the con- 
trol level. The antibodies responsible for immunosuppression could be removed 
from this serum, as could the NIP-binding antibodies, by absorption with NIP 
coupled through ethylenediamine to insoluble Sepharose.  The  ability of this 
serum to augment the response was not reduced by such absorption. Augment- 
ing  antibodies  could  be  removed  by  absorption  with  HOP-BSA-Sepharose. 
Thus,  immunosuppression  and  augmentation are  functions of  two  different G.  HAUGHTON AND O.M.AKELA  115 
populations  of antibody.  The  former are  specific  hapten-binding  antibodies, 
the latter seem to be directed against new antigenic determinants created by 
coupling any of the  family of haptens  through lysine  to protein  carriers.  In 
support of this contention, it was observed that rabbit antiserum to NP-CG, 
after  absorption  with  CG-Sepharose,  augmented  the  response  of  mice  to 
standard immunization with NIP12-CG. 
Female  mice produced  significantly more NIP-binding antibody than  did 
males. 
We are indebted to Mrs. Kaija Rytsy for skillful technical assistance. 
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